Naiel Nassar, MD
Professor
Infectious Diseases- Fresno
School of Medicine

Infectious Diseases Division Director/Program Director Antibiotic Stewardship Director Professor of Clinical Medicine, UCSF

Naiel Nassar, M.D., specializes in infectious diseases. He is board certified in Internal Disease and Infectious Disease. His fellowship training was completed at the University of California, Davis.

He was appointed as a faculty member in the Division of Infectious Diseases and the Medical Director of the Center for AIDS Research, Education and Services (CARES) in Sacramento.

• Fixed-bed column studies of total organic carbon removal from industrial wastewater by use of diatomite decorated with polyethylenimine-functionalized pyroxene nanoparticles.
  Journal of colloid and interface science 2017 Hethnawi A, Manasrah AD, Vitale G, Nassar NN
• Real-time genomic profiling of histiocytoses identifies early-kinase domain BRAF alterations while improving treatment outcomes.
  JCI insight 2017 Lee LH, Gasilina A, Roychoudhury J, Clark J, McCormack FX, Pressey J, Grimley MS, Lorsbach R, Ali S, Bailey M, Stephens P, Ross JS, Miller VA, Nassar NN, Kumar AR
• The Ying and Yang of Adenosine A1 and A2A Receptors on ERK1/2 Activation in a Rat Model of Global Cerebral Ischemia Reperfusion Injury.
  Molecular neurobiology 2017 Atef RM, Agha AM, Abdel-Rhaman AA, Nassar NN
• Octreotide ameliorates inflammation and apoptosis in acute and kindled murine PTZ paradigms.
  Naunyn-Schmiedeberg's archives of pharmacology 2016 Al-Shorbagy MY, Nassar NN
• The effect of the nanosize on surface properties of NiO nanoparticles for the adsorption of Quinolin-65.
  Physical chemistry chemical physics : PCCP 2016 Marei NN, Nassar NN, Vitale G
• UBASH3B/Sts-1-CBL axis regulates myeloid proliferation in human preleukemia induced by AML1-ETO.
  Leukemia 2015 Goyama S, Schibler J, Gasilina A, Shrestha M, Lin S, Link KA, Chen J, Whitman SP, Bloomfield CD, Nicolet D, Assi SA, Ptasinska A, Heidenreich O, Bonifer C, Kitamura T, Nassar NN, Mulloy JC
• Maghemite nanosorbcats for methylene blue adsorption and subsequent catalytic thermo-oxidative decomposition: Computational modeling and thermodynamics studies.
  Journal of colloid and interface science 2015 El-Qanni A, Nassar NN, Vitale G, Hassan A
• A man with oral lesions, constipation and back pain.
  International journal of STD & AIDS 2013 Mu A, Nassar N
• Enhanced efficacy and reduced side effects of diazepam by kava combination.
  Journal of advanced research 2013 Tawfiq RA, Nassar NN, El-Eraky WI, El-Denshary ES
• Time to virological failure with atazanavir/ritonavir and lopinavir/ritonavir, with or without an H2-receptor blocker, not significantly different in HIV observational database study.
  International journal of STD & AIDS 2008 Keiser PH, Nassar N
• Abacavir sulfate/lamivudine/zidovudine fixed combination in the treatment of HIV infection.
  Expert opinion on pharmacotherapy 2007 Keiser P, Nassar N
• Comparison of efficacy of efavirenz and nevirapine: lessons learned for cohort analysis in light of the 2NN Study.
  HIV clinical trials 2003 Keiser P, Nassar N, Yazdani B, Armas L, Moreno S
• Comparison of symptoms of influenza A with abacavir-associated hypersensitivity reaction.
  International journal of STD & AIDS 2003 Keiser P, Nassar N, Skiest D, Andrews C, Yazdani B, White A, Hetherington S
• Trizivir.
  Expert opinion on pharmacotherapy 2002 Keiser P, Nassar N
• Coordinated community programs for HIV prevention among intravenous-drug users--California, Massachusetts.
  MMWR. Morbidity and mortality weekly report 1989 Centers for Disease Control (CDC)